ABSTRACT
Abstract Purpose: The effect of a prophylactic oleuropein-rich diet before anesthesia accompanied by the widely-used steroid-based neuromuscular drug rocuronium on mast cell activation was investigated in the study. Methods: 14 rabbits used in the study. The rabbits in the oleuropein group were given oleuropein-rich extract added to the animals' water at doses of 20 mg/kg oleuropein for 15 days orally. After 15 days, all rabbits in the two groups were given general anesthesia with rocuronium of 1 mg/kg. After 1 day, animals were sacrificed and the liver tissue sections stained with H&E, toluidine blue and tryptase for immunohistochemical study. Results: There was no statistically significant difference between ALT, AST and albumin averages of the oleuropein and control groups (p> 0.05). The tryptase average of the control group was higher than the tryptase average of the oleuropein group and this difference was statistically significant (p=0.003). The T. blue average in the oleuropein group was higher than the control group. However, there was no statistically significant difference between groups (p=0.482). Conclusions: Rocuronium adverse effects, like hypersensitivity and anaphylaxis, may limit routine use of this substance. The use of oleuropein reduced the number of inflammatory cells and prevented degranulation.
Subject(s)
Animals , Male , Rabbits , Neuromuscular Nondepolarizing Agents/adverse effects , Iridoids/administration & dosage , Rocuronium/adverse effects , Anesthesia, General/adverse effects , Mast Cells/drug effects , Anti-Inflammatory Agents/administration & dosage , Aspartate Aminotransferases/blood , Serum Albumin/analysis , Random Allocation , Cell Degranulation/drug effects , Cell Aggregation/drug effects , Reproducibility of Results , Chromatography, High Pressure Liquid , Diet Therapy/methods , Alanine Transaminase/blood , Drug-Related Side Effects and Adverse Reactions/prevention & control , Pre-Exposure Prophylaxis/methods , Liver/drug effects , Liver/enzymology , Mast Cells/pathologyABSTRACT
Connective tissue growth factor (CCN2/CTGF) is a matricellular-secreted protein involved in extracellular matrix remodeling. The P19 cell line is an embryonic carcinoma line widely used as a cellular model for differentiation and migration studies. In the present study, we employed an exogenous source of CCN2 and small interference RNA to address the role of CCN2 in the P19 cell aggregation phenomenon. Our data showed that increasing CCN2 protein concentrations from 0.1 to 20 nM decreased the number of cell clusters and dramatically increased cluster size without changing proliferation or cell survival, suggesting that CCN2 induced aggregation. In addition, CCN2 specific silencing inhibited typical P19 cell aggregation, which could be partially rescued by 20 nM CCN2. The present study demonstrates that CCN2 is a key molecule for cell aggregation of embryonic P19 cells.
Subject(s)
Humans , Cell Aggregation/drug effects , Cell Proliferation/drug effects , Connective Tissue Growth Factor/pharmacology , Embryonal Carcinoma Stem Cells/drug effects , Cell Adhesion , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/physiologyABSTRACT
Aggregation mechanism and deformability in pentoxifylline- and dispirin-treated erythrocytes are measured and compared with that of normal cells. The aggregation process is analyzed in terms of parameters which are obtained from the sequential recording of the transmitted light signal throughout the aggregate formation and sedimentation process. Erythrocyte deformability is determined by measurement of passage time through cellulose membrane. The variations in aggregation parameters in pentoxifylline-treated samples show that the formed aggregates are of larger size which sediment faster. In dispirin-treated cells, the formation of large size aggregates is delayed. The entire process is completed faster in pentoxifylline-treated compared to that of dispirin-treated cell whereas the normal sample shows an intermediate value. The deformability of erythrocytes treated with these drugs is increased.
Subject(s)
Aspirin/pharmacology , Cell Aggregation/drug effects , Erythrocyte Deformability/drug effects , Erythrocytes/cytology , Humans , Pentoxifylline/pharmacology , Vasodilator Agents/pharmacologyABSTRACT
Histamine and 2-methyl histamine caused dose-dependent aggregation of melanophores in toad B. melanostictus. The effects were effectively antagonised by mepyramine, a specific H1 histamine receptor antagonist, and metiamide a specific H2 receptor antagonist. On the other, hand 4-methyl histamine, a specific H2 receptor agonist dispersed the melanophores. The results suggest that adult Bufo melanophores have H1 histamine receptors which mediate melanophore aggregation, however, dispersion of melanophores may be controlled by undifferentiated histamine receptors of H2 type.
Subject(s)
Animals , Bufonidae , Cell Aggregation/drug effects , Histamine/pharmacology , Histamine Agents/pharmacology , Melanophores/drug effects , Methylhistamines/pharmacology , Metiamide/pharmacology , Pyrilamine/pharmacologyABSTRACT
Melanin concentrating hormone (MCH: 5 x 10(-12)-5 x 10(-8) M) induced a concentration related, rapid and reversible pigment aggregation in innervated melanophores of Labeo rohita. In inducing melanosome aggregation MCH was found to be 10(4) times more potent than norepinephrine. Experiments employing phentolamine and propranolol suggest that MCH acts through its own specific receptors on the melanophores unrelated to adrenoceptors. MCH was able to aggregate the melanosomes even in the absence of extracellular Ca2+.